ClinicalTrials.gg
Not yet recruitingNCT07800559SISUpdated Sep 2, 2026

The Combined Effect of Thoracic Manipulation and Instrument-assisted Soft Tissue Mobilization in Patients With Shoulder Impingement Syndrome

An interventional study of conventional physical therapy and thoracic manibulation in Shoulder Impingement Syndrome, sponsored by Cairo University. Not yet recruiting. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 30 studies in Shoulder Impingement Syndrome by Cairo University — 14 open to participants now, 16 under way, none of them phase 3. Shoulder Impingement Syndrome · Cairo University.

Planned enrollment
Largest of 26
80 · median 49
Started
2026
with 5 others
No phase
26 of 30
11 open now
Primary completion
2027-05
later than 14 of 15 live
Registered
30th of 30
by date

Among the 30 studies in Shoulder Impingement Syndrome by Cairo University, this one has the largest planned enrollment of the 26 interventional ones that give a count, is one of 6 that started in 2026, is one of 26 with no phase, reaches primary completion later than 14 of the 15 other live ones, and was the 30th registered.

Shoulder Impingement Syndrome

320 studies on the registry are indexed under Shoulder Impingement Syndrome; 62 are open to participants now.

Browse Shoulder Impingement Syndrome studies →

Open to participants now

14 of the 30 studies in Shoulder Impingement Syndrome by Cairo University are open now, in 1 country. Recruiting first, the newest first:

8 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Where they have run

Who these studies take

Of the 32 Shoulder Impingement Syndrome studies recruiting now, 3 (9%) set no upper age limit and 25 (78%) stop at 75 or younger; 1 takes children under 18; 6 take healthy volunteers.

This study: 18 Years to 55 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 30 studies in Shoulder Impingement Syndrome by Cairo University, or all of them as a file.
02

Study summary

This study will be conducted to investigate the combined effect of thoracic manipulation and instrument-assisted soft tissue mobilization in patients with shoulder impingement syndrome

Read the detailed description

Shoulder impingement syndrome (SIS) represents one of the most prevalent musculoskeletal disorders affecting the upper extremity, accounting for 44-65% of all shoulder complaints in clinical practice. The condition is characterized by mechanical compression of the rotator cuff tendons and subacromial bursa beneath the coracoacromial arch during arm elevation, resulting in pain, inflammation, and reduced quality of life. Thoracic spinal manipulation aims to restore mobility and optimize scapular positioning. Studies have shown that adding Maitland thoracic manipulation or Mulligan SNAGs to exercise leads to superior improvements in pain and range of motion.Thoracic spine manipulation (TSM) is one of the techniques that can be used to gain thoracic mobility in peoples with shoulder dysfunction Instrument-assisted soft tissue mobilization (IASTM) uses specialized tools to treat myofascial restrictions. It triggers a localized inflammatory response that initiates healing and remodeling. While promising in tendinopathy cases, there is a significant evidence gap regarding its efficacy when combined with joint-based manual therapy for SIS. Investigating the synergistic effects of combining these regional and local interventions with foundational scapular stabilization exercises will provide a comprehensive, evidence-based framework that is currently lacking in the literature.

03

Conditions studied

  • Shoulder Impingement Syndrome

Keywords

  • Thoracic Manipulation
  • Instrument-assisted Soft Tissue Mobilization
  • Shoulder Impingement Syndrome
04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with shoulder impingement syndrome from both genders their age from 18-55 years.
  • History of shoulder pain for one month.
  • Positive Neer's impingement test and Hawkin's Kennedy test.
  • Painful arc sign.

Exclusion criteria

Exclusion Criteria:

  • History of Shoulder girdle fracture, dislocation and surgery
  • Diagnosed with frozen shoulder or rotator cuff tear
  • History of cervicobrachial pain
  • Any neuromuscular pain in upper limb and use of or pain subsiding medication.
  • Inflammatory arthropathies (e.g., rheumatoid arthritis, ankylosing spondylitis).
  • Fracture or in the shoulder region
  • to manual therapy or thoracic manipulation (e.g., osteoporosis, spinal cord compression, vertebral artery insufficiency).
  • Contraindications to IASTM (e.g., open wounds, skin infections, bleeding disorders, anticoagulant therapy).
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    conventional physical therapy

    Twenty patients with shoulder impingement syndrome will receive conventional physical therapy three times per week for 6 weeks

    Other: conventional physical therapy

  • Experimental
    thoracic manibulation

    twenty patients with shoulder impingement syndrome will receive thoracic manibulation plus conventional physical therapy three times per week for 6 weeks

    Other: conventional physical therapy · Other: thoracic manibulation

  • Experimental
    nstrument assisted soft tissue mobilization

    twenty patients with shoulder impingement syndrome will receive conventional physical therapy and instrument-assisted soft tissue mobilization three times per week for 6 weeks

    Other: conventional physical therapy · Other: instrument assisted soft tissue mobilization

  • Experimental
    thoracic manipulation and instrument-assisted soft tissue mobilization.

    twenty patients with shoulder impingement syndrome will receive thoracic manipulation + instrument-assisted soft tissue mobilization. The conventional physical therapy three times per week for 6 weeks

    Other: conventional physical therapy · Other: thoracic manibulation · Other: instrument assisted soft tissue mobilization · Other: thoracic manipulation and instrument-assisted soft tissue mobilization

Interventions

  • Otherconventional physical therapy

    the patients will receive conventional physical therapy in the form of transcutaneous electrical nerve stimulation, ultrasound, and therapeutic exercise. The exercise includes range of motion exercises, stretching, scapular stabilization exercises, and rotator cuff strengthening.

  • Otherthoracic manibulation

    With the participant in a prone position, the therapist will apply a high-velocity, short-lever, posterior-to-anterior (P-A) thrust. The thrust will be directed toward the spinous or transverse processes of the hypomobile thoracic vertebrae. Thoracic thrust manipulation demonstrated to manipulate specific thoracic segment mainly the mid-thoracic, plus conventional physical therapy.

  • Otherinstrument assisted soft tissue mobilization

    The IASTM technique will be performed for 20 seconds parallel to the muscle fibers, followed by 20 seconds perpendicular to the muscle fibers, with the instrument held at a 45° angle to the skin. The beveled side of the M2T blade will be in contact with the skin. Stroke pressure and speed will be modified according to the participant's tolerance to avoid causing pain and according to the depth of the treated muscle plus conventional physical therapy.The technique will be applied to the pectoral muscles, shoulder rotator cuff musculature, and periscapular musculature, including the upper, middle, and lower fibers of the trapezius, rhomboids major and minor, teres major, and latissimus dorsi

  • Otherthoracic manipulation and instrument-assisted soft tissue mobilization

    the patients will receive The IASTM technique will be performed for 20 seconds parallel to the muscle fibers followed by 20 seconds perpendicular to the muscle fibers, with the instrument held at a 45° angle to the skin plus thoracic manibulation in which the therapist will apply a high-velocity, short-lever, posterior-to-anterior (P-A) thrust. The thrust will be directed toward the spinous or transverse processes of the hypomobile thoracic vertebrae. Thoracic thrust manipulation demonstrated to manipulate specific thoracic segments, mainly the mid-thoracic, plus conventional physical therapy. finally, the pateitns will recieve conventional physical therapy

06

What researchers measure

Primary outcomes

  1. upper limb disability

    Disabilities of the arm, shoulder and hand (Quick DASH) questionnaire will be used toassess upper limb diability.the QuickDASH only contains 11 items .It is a questionnaire that measures an individual's ability to complete tasks, absorb forces, and severity of symptoms.The QuickDASH tool uses a 5-point Likert scale from which the patient can select an appropriate number corresponding to his/her severity/function level.The QuickDASH outcome measure is designed to be used on patients presenting with one or more disabilities of the arm, shoulder, and hand. Scoring with 100 is more severe disability, and zero mean no disability.

    Time frame: up to six weeks

Secondary outcomes

  1. pain intensity

    neumerical pain rating scale will be used to assess pain. It consists of a line, often 10 cm long (100mm); its ends are generally labelled with verbal pain anchors (e.g., "no pain" and "pain as bad as it could be"). Patients are asked to indicate the point along the line from 0-10 cm marked in 1 cm increments where 0 cm represents no pain and 10 cm the most severe pain imaginable

    Time frame: up to 6 weeks

  2. shoulder range of motion

    The Digital goniometer will be used to assess shoulder range of motion.

    Time frame: up to six weeks

  3. shoulder proprioception (joint position error)

    shoulder joint position error will be assessed by a smartphone clinometer application. Proprioception test was done by moving the participant's arms from the starting position (0 degrees) to the target angles. The arm remained at each target angle for 5 seconds, allowing the subjects to memorize the position before returning to the starting position. Subsequently, the subjects were instructed to independently move their arms towards each target angle.

    Time frame: up to six weeks

  4. life disability

    World Health Organization Quality of Life BREF will be used to assess life disability. The WHOQOL-BREF is a 26-item instrument that assesses quality of life across four domains: physical health (items 3, 4, 10, 15, 16, 17, and 18), psychological health (items 5, 6, 7, 11, 19, and 26), social relationships (items 20, 21, and 22), and environment (items 8, 9, 12, 13, 14, 23, 24, and 25). Items 1 and 2 assess overall quality of life and general health, respectively. Each item is rated on a 5-point Likert scale from 1 to 5. Items 3 and 4 are reverse-scored. For each domain, the item scores are averaged and multiplied by 4, producing a domain score ranging from 4 to 20, with higher scores indicating better quality of life.

    Time frame: up to six weeks

  5. pressure pain threshold

    pressure pain threshold wil be assessed by algometer.During the assessment, the patient is instructed to indicate the exact moment the sensation transitions from comfortable pressure to the onset of pain, effectively translating a subjective experience into an objective, measurable value (typically recorded in kg/cm² or Newtons).

    Time frame: up to six weeks

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for May 2027, 8 months later.

Of 170 non-industry interventional studies with no phase under Shoulder Impingement Syndrome, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 8 months is below that.

Counting every sponsor, half of 172 studies reached it within 12 months; a quarter within 5 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 29, 2026
First posted
Sep 2, 2026
StartEst.
Sep 10, 2026
Primary completionEst.
May 10, 2027
CompletionEst.
May 10, 2027
Last update
Sep 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07800559
Lead sponsor
Cairo University
Responsible party
Nabil Mahmoud Ismail Abdel-Aal (principle investigator : nabil mahmoud ismail, Cairo University) — Principal investigator
First posted
Sep 2, 2026
Start date
Sep 10, 2026 (estimated)
Primary completion
May 10, 2027 (estimated)
Completion
May 10, 2027 (estimated)
Last update
Sep 2, 2026

Study contacts

Nabil mahmoud, professor
Contact
nabil.mahmoud@cu.edu.eg
+20 12 00133613
mahmoud kashef, phd
Contact
Mahmoud.kashef92@gmail.com
+20 10 94523424

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion